Neuroprotective effects of eliprodil in retinal excitotoxicity and ischemia

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 6, 1999, Pages 1177-1182

  Kapin, Michael A ^a   Doshi, Rupa ^a   Scatton, Bernard ^b   DeSantis, Louis M ^a   Chandler, Michael L ^a  

^a ALCON RESEARCH LTD   (United States)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; ELIPRODIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL PROTECTION; ELECTRORETINOGRAPHY; INTRAOCULAR PRESSURE ABNORMALITY; NEUROPROTECTION; NONHUMAN; OPTIC NERVE; PRIORITY JOURNAL; RECEPTOR BINDING; RETINA GANGLION CELL; RETINA ISCHEMIA; SYSTOLIC BLOOD PRESSURE;

ANIMALS; CHOLINE O-ACETYLTRANSFERASE; ELECTRORETINOGRAPHY; INJECTIONS; INJECTIONS, INTRAPERITONEAL; ISCHEMIA; N-METHYLASPARTATE; NEUROPROTECTIVE AGENTS; NEUROTOXINS; PIPERIDINES; RATS; RATS, LONG-EVANS; RETINA; RETINAL GANGLION CELLS; RETINAL VESSELS; VITREOUS BODY;

EID: 0032900575     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Bresnick GH. Excitotoxins: a possible new mechanism for the pathogenesis of ischemic retinal damage. Arch Ophthalmol. 1989; 107:339-341.
2. Robin LN, Kalloniatis M. Interrelationship between retinal ischemic damage and turnover and metabolism of putative amino acid neurotransmitters, glutamate and GABA. Doc Ophthalmol. 1992; 80:273-300.
3. Schumer RA, Podos SM. The nerve of glaucoma! Arch Ophthalmol. 1994;112:37-44.
4. Cummins D, Takahaski N, Caprioli J. Electrophysiology of cultured retinal ganglion cells to investigate basic mechanisms of damage. Glaucoma Update. 1991;IV:59-65.
5. Kitano S, Morgan J, Caprioli J. Hypoxic and excitotoxic damage to cultured rat retinal ganglion cells. Exp Eye Res. 1996;63:105-112.
6. Pang I-H, Wexler EM, Walters RJ, Nawy S, Kapin MA. Protection by eliprodil against excitotoxicity in cultured rat retinal ganglion cells. Invest Ophthalmol Vis Sci. 1999;40:1170-1176.
7. Sucher NJ, Aizenman E, Lipton SA. N-methyl-D-aspartate antagonists prevent kainate neurotoxicity in rat retinal ganglion cells in vitro. J Neurosci. 1991;11:966-971.
8. Blanks JC. Effects of monosodium glutamate on the isolated retina of the chick embryo as a function of age: a morphological study. Exp Eye Res. 1981;32:105-124.
9. David P, Lusky M, Teichberg VI. Involvement of excitatory neurotransmitters in the damage produced in chick embryo retinas by anoxia and extracellular high potassium. Exp Eye Res. 1988;46: 657-662.
10. Olney JW, Price MT, Fuller TA, et al. The anti-excitotoxic effects of certain anesthetics, analgesics and sedative-hypnotics. Neurosci Lett. 1986;68:29-34.
11. Olney JW, Price MT, Samson L, Labruyere J. The role of specific ions in glutamate neurotoxicity. Neurosci Lett. 1986;65:65-71.
12. Price MT, Honore T, Mueller ME, Labruyere J, Silverman E, Olney JW. CNQX potently and selectively blocks kainate excitotoxicity in the chick embryo retina. Soc Neurosci Abstr. 1988;14:418.
13. Reif-Lehrer L, Bergenthal J, Harininen L. Effects of monosodium glutamate on chick embryo retina in culture. Invest Ophthalmol Vis Sci. 1975;14:114-124.
14. Sattayasai J, Ehrlich D. Morphology of quisqualate-induced neurotoxicity in the chicken retina. Invest Ophthalmol Vis Sci. 1987; 28:106-117.
15. Siliprandi R, Canella R, Carmignoto G, et al. N-methyl-D-aspartate-induced neurotoxicity in the adult rat retina. Vis Neurosci. 1992; 8:567-573.
16. Sisk DR, Kuwabara T. Histologic changes in the inner retina of albino rats following intravitreal injection of monosodium L-glutamate. Graefes Arch Clin Exp Ophthalmol. 1985;223:250-258.
17. Tung NN, Morgan IG, Ehrlich D. A quantitative analysis of the effects of excitatory amino acids in retinal ganglion cells in the chick. Vis Neurosci. 1990;4:217-223.
18. Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol. 1996;114:299-305.
19. Beal MF. Mechanisms of excitotoxicity in neurologic diseases. FASEB J. 1992;6:3338-3344.
20. Choi DW. Excitotoxic cell death. J Neurobiol. 1992;23:1261-1276.
21. Block F, Pergande G, Schwarz M. Flupirtine protects against ischaemic retinal dysfunction in rats. Neuroreport. 1994;5:2630-2632.
22. Yoon YH, Marmor MF. Dextromethorphan protects retina against ischemic injury in vivo. Arch Ophthalmol. 1989;107:409-411.
23. Lipton SA. Prospects for clinically tolerated NMDA antagonists: open-channel blockers and alternative redox states of nitric oxide. Trends Neurosci. 1993;16:527-532.
24. Scatton B, Carter C, Benavides J, Giroux C. N-methyl-D-aspartate receptor antagonists: a novel therapeutic perspective for the treatment of ischemic brain injury. Cerebrovasc Dis. 1991;1:121-135.
25. Whittemore ER, Ilyin VI, Woodward RM. Antagonism of N-methyl-D-aspartate receptors by sigma site ligands: potency, subtype-selectivity and mechanisms of inhibition. J Pharmacol Exp Ther. 1997;282:326-338.
26. Carter CJ, Lloyd KG, Zivkovic B, Scatton B. Ifenprodil and SL 82.0715 as cerebral antiischemic agents, III: evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex. J Pharmacol Exp Ther. 1990;253:475-482.
27. Scatton B, Avenet P, Benavides J, et al. Neuroprotective potential of the polyamine site-directed NMDA receptor antagonists - ifenprodil and eliprodil. In: Palfreyman MG, Reynolds IJ, Skolnick P, eds. Direct and Allosteric Control of Glutamate Receptors. Boca Raton, FL: CRC Press Inc; 1994:139-154.
28. Scatton B, Giroux C, Thenot JP, et al. Eliprodil hydrochloride. Drugs Future. 1994;19:905-909.
29. Fonnum F. A rapid method for the determination of choline acetyl transferase. J Neurochem. 1975;24:407-409.
30. 2+ channels in rat cultured cortical neurons. Eur J Pharmacol. 1994;257:297-301.
31. 3H]ifenprodil, a novel NMDA antagonist, to a polyamine-sensitive site in the rat cerebral cortex. Eur J Pharmacol. 1990;176:249-250.
32. Reyes M, Reyes A, Nawy S, Kapin MA, Stanton PK. The NMDA polyamine-site antagonist eliprodil protects hippocampal pyramidal neurons from hypoxic/ischemic damage. Brain Res. 1998;782: 212-218.
33. Gotti B, Duverger D, Bertin J, et al. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents, I: evidence for efficacy in models of focal cerebral ischemia. J Pharmacol Exp Ther. 1988;247:1211-1221.
34. Gotti B, Benavides J, MacKenzie ET, Scatton B. The pharmacotherapy of focal cortical ischaemia in the mouse. Brain Res. 1990;522: 290-307.
35. Toulmond S, Serrano A, Benavides J, Scatton B. Prevention by eliprodil (SL 82.0715) of traumatic brain damage in the rat: existence of a large (18 h) therapeutic window. Brain Res. 1993;620: 32-41.
36. Samy CN, Lui CJ, Kaiser PK, Lipton SA, Dreyer EB. Toxicity of chronic glutamate administration to the retina [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1994;35(4):S1361. Abstract nr 497.
37. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med. 1994;330: 613-622.
38. Marmor MF, Dalal R. Irregular retinal and RPE damage after pressure-induced ischemia in the rabbit. Invest Ophthalmol Vis Sci. 1993;34:2570-2575.